PDLI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
PDL BioPharma Inc's account receivable for the three months ended in Mar. 2015 was $63.4 Mil. PDL BioPharma Inc's revenue for the three months ended in Mar. 2015 was $149.7 Mil. Hence, PDL BioPharma Inc's days sales outstanding for the three months ended in Mar. 2015 was 38.67.
PDL BioPharma Inc's days sales outstanding increased from Mar. 2014 (7.77) to Mar. 2015 (38.67).
Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Account receivable can be measured by Days Sales Outstanding.
PDL BioPharma Inc's Days Sales Outstanding for the fiscal year that ended in Dec. 2014 is calculated as
PDL BioPharma Inc's Days Sales Outstanding for the quarter that ended in Mar. 2015 is calculated as:
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
PDL BioPharma Inc Annual Data
PDL BioPharma Inc Quarterly Data